Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients.
Leukemia
; 28(4): 967-70, 2014 Apr.
Article
in En
| MEDLINE
| ID: mdl-24441289
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Humans
Language:
En
Journal:
Leukemia
Year:
2014
Document type:
Article